CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is the fourth leading cause of cancer-related death in Western countries. Although several therapeutic strategies have been developed for pancreatic cancer, radiation therapy has not yet yielded satisfactory results. Unraveling the mechanism of radioresistance in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Bin, Zeng, Siyuan, Zhang, Shuman, Ren, Xiaofan, Xing, Yuming, Kutschick, Isabella, Pfeffer, Susanne, Frey, Benjamin, Britzen-Laurent, Nathalie, Grützmann, Robert, Cordes, Nils, Pilarsky, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773906/
https://www.ncbi.nlm.nih.gov/pubmed/35053488
http://dx.doi.org/10.3390/cancers14020326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773906/
https://www.ncbi.nlm.nih.gov/pubmed/35053488
http://dx.doi.org/10.3390/cancers14020326

Ejemplares similares